LGM Pharma API Sourcing. CDMO Services, Regulatory Expertise. LGM Pharma API Sourcing. CDMO Services, Regulatory Expertise.

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Leo Pharma aggregated by PharmaCompass.com.

    Client Virtual Booth

    LEO PHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Leo Pharma
    Denmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Industriparken 55
    Telephone
    Telephone
    +45 4494 5888
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.leo-pharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Leo censured for ‘extremely concerning' drug marketing breach
    Leo censured for ‘extremely concerning' drug marketing breach

    https://www.fiercepharma.com/marketing/leo-loses-appeal-against-uks-most-serious-drug-marketing-breach-its-censured-extremely

    Ben Adams FIERCE PHARMA
    31 Mar 2023
    Share Share
    LEO Pharma Presents Positive Phase 2a Efficacy Results of LEO 138559
    LEO Pharma Presents Positive Phase 2a Efficacy Results of LEO 138559

    https://www.businesswire.com/news/home/20230318005014/en

    BUSINESSWIRE
    18 Mar 2023
    Share Share
    LEO Presents Adbry Data in Population from ECZTRA 6 and ECZTEND Trials
    LEO Presents Adbry Data in Population from ECZTRA 6 and ECZTEND Trials

    https://www.businesswire.com/news/home/20230317005158/en

    BUSINESSWIRE
    17 Mar 2023
    Share Share
    Further shuffling at Leo Pharma as dermatology drugmaker splits R&D
    Further shuffling at Leo Pharma as dermatology drugmaker splits R&D

    https://endpts.com/further-shuffling-at-leo-pharma-as-dermatology-drugmaker-splits-rd/

    Kyle LaHucik ENDPTS
    14 Mar 2023
    Share Share
    LEO Adds Internationally Recognized Dermatologist to Global Leadership Team
    LEO Adds Internationally Recognized Dermatologist to Global Leadership Team

    https://www.businesswire.com/news/home/20230314005699/en

    BUSINESSWIRE
    14 Mar 2023
    Share Share
    LEO Pharma, ICON Partner to Advance Clinical Trials in Dermatology
    LEO Pharma, ICON Partner to Advance Clinical Trials in Dermatology

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-10/leo-pharma-icon-partner-to-advance-clinical-trials-in-dermatology/?widget=listSection

    CONTRACT PHARMA
    10 Mar 2023
    Share Share
    LEO Pharma and ICON Enter a Strategic Partnership to Propel Trial Execution
    LEO Pharma and ICON Enter a Strategic Partnership to Propel Trial Execution

    https://www.businesswire.com/news/home/20230310005162/en

    BUSINESSWIRE
    10 Mar 2023
    Share Share
    Leo Pharma scores in phase 3 trial for JAK inhibitor cream
    Leo Pharma scores in phase 3 trial for JAK inhibitor cream

    https://www.fiercepharma.com/pharma/leo-pharmas-topical-jak-touts-promising-phase-3-data-chronic-hand-eczema

    Zoey Becker FIERCE PHARMA
    13 Feb 2023
    Share Share
    LEO Announces Positive PIII Results From DELTA 2 Trial With Delgocitinib
    LEO Announces Positive PIII Results From DELTA 2 Trial With Delgocitinib

    https://www.businesswire.com/news/home/20230209005440/en/LEO-Pharma-Announces-Positive-Phase-3-Topline-Results-From-DELTA-2-Trial-With-Delgocitinib-Cream-in-Adults-With-Moderate-to-Severe-Chronic-Hand-Eczema-CHE-Confirming-the-Positive-Results-of-the-Recent-DELTA-1-Trial

    BUSINESSWIRE
    10 Feb 2023
    Share Share
    Japan Approves Manufacturing and Marketing of Adtralza in Japan
    Japan Approves Manufacturing and Marketing of Adtralza in Japan

    https://www.businesswire.com/news/home/20221223005048/en/Japan-Ministry-of-Health-Labor-and-Welfare-Approves-Manufacturing-and-Marketing-of-Adtralza%C2%AE-tralokinumab-in-Japan-for-Adults-with-Atopic-Dermatitis

    BUSINESSWIRE
    24 Dec 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    pfizer-centreone-m-2023-06-05

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search